$科兴生物(SVA)$ 最新柳叶刀子刊文章，在防止奥密克戎感染后住院率上，科兴完胜复必泰

The effectiveness against hospitalization during the Omicron dominance in the 60+ years old population started at 61.7% (95% CI, 26.1–86.2) for ChAdOx1, 95.6% (95% CI, 82.4–99.9) for CoronaVac, and 72.3% (95% CI, 51.4–87.4) for the BNT162b2 vaccine.

网页链接(23)00039-X/fulltext